540250
(S)-(+)-1,2-Propanediol
96%
Synonym(s):
(S)-(+)-Propylene glycerol
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3CH(OH)CH2OH
CAS Number:
Molecular Weight:
76.09
UNSPSC Code:
12352001
NACRES:
NA.22
PubChem Substance ID:
MDL number:
Beilstein/REAXYS Number:
1718871
Assay:
96%
Quality Level
assay
96%
optical activity
[α]20/D +16.5°, neat
optical purity
ee: 98% (GLC)
refractive index
n20/D 1.432 (lit.)
bp
186-188 °C/765 mmHg (lit.)
density
1.036 g/mL at 20 °C (lit.)
functional group
hydroxyl
SMILES string
C[C@H](O)CO
InChI
1S/C3H8O2/c1-3(5)2-4/h3-5H,2H2,1H3/t3-/m0/s1
InChI key
DNIAPMSPPWPWGF-VKHMYHEASA-N
Application
(S)-(+)-1,2-Propanediol can be used as a reactant to synthesize:
- Optically active chiral (S)-1, 2-propanediol derivatives using mesogenic carboxylic acids via esterification in the presence of dimethylaminopyridine (DMAP) as a catalyst.
- 3,4-Ethylenedioxythiophenes via Mitsunobu reaction.
- Vicinal diol cyclic sulfates in the presence of sodium periodate and ruthenium chloride as catalysts.
Storage Class
10 - Combustible liquids
wgk
WGK 3
flash_point_f
217.4 °F - closed cup
flash_point_c
103 °C - closed cup
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Dae-Hee Lee et al.
Applied and environmental microbiology, 76(13), 4158-4168 (2010-05-04)
Laboratory adaptive evolution studies can provide key information to address a wide range of issues in evolutionary biology. Such studies have been limited thus far by the inability of workers to readily detect mutations in evolved microbial strains on a
Carla Caddeo et al.
International journal of pharmaceutics, 443(1-2), 128-136 (2013-01-10)
Diclofenac-loaded phospholipid vesicles, namely conventional liposomes, ethosomes and PEVs (penetration enhancer-containing vesicles) were developed and their efficacy in TPA (phorbol ester) induced skin inflammation was examined. Vesicles were made from a cheap and unpurified mixture of phospholipids and diclofenac sodium;
A A Melo et al.
The Journal of laryngology and otology, 127(4), 359-363 (2013-02-15)
To determine whether the administration of mitomycin C prevents propylene glycol exposure from inducing middle-ear cholesteatoma and otitis media, in a rat model. Twenty-four Wistar rats underwent intratympanic injections on days 1, 8 and 15, via the tympanic membrane pars